This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glynn, R. J. Articles by Buring, J. E. Search for Related Content PubMed PubMed Citation Articles by Glynn, R. J. Articles by Buring, J. E. Related Collections Cerebrovascular disease/stroke Risk Factors Clinical Studies CV surgery: coronary artery disease Acute myocardial infarction Epidemiology

(Hypertension. 2002;39:105.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Development of Predictive Models for Long-Term Cardiovascular Risk Associated With Systolic and Diastolic Blood Pressure

Robert J. Glynn; Gilbert J. L’Italien; Howard D. Sesso; Elizabeth A. Jackson; Julie E. Buring

From the Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School (R.J.G., H.D.S., E.A.J., J.E.B.), Boston, Mass; the Department of Biostatistics (R.J.G.) and the Department of Epidemiology (H.D.S., J.E.B.), Harvard School of Public Health, Boston, Mass; Bristol-Myers Squibb, Pharmaceutical Research Institute (G.J.L.), Wallingford, Conn; and the Department of Ambulatory Care and Prevention, Harvard Medical School (J.E.B.), Boston, Mass.

Correspondence to Robert J. Glynn, ScD, Division of Preventive Medicine, Brigham and Women’s Hospital, 900 Commonwealth Ave E, Boston, MA 02215-1204. E-mail rglynn{at}rics.bwh.harvard.edu

Most existing risk prediction models have not considered the joint contribution of systolic and diastolic blood pressure to cardiovascular risk, and some suggest that there are thresholds below which further reductions of blood pressure yield no additional benefit. We developed multivariate risk prediction models that quantify the risk associated with both systolic and diastolic blood pressure and that can be used to infer the benefits of antihypertensive therapy in populations. Two large clinical trial cohorts, the Physicians’ Health Study, composed of 22 071 males (mean age, 53.2 years; median follow-up, 13.0 years), and the Women’s Health Study, composed of 39 876 females (mean age, 53.8 years; median follow-up, 6.2 years), were used to develop gender-specific predictive models via Cox regression. End points included myocardial infarction, stroke, coronary artery bypass, angioplasty, and cardiovascular death. Risk reduction estimates were derived by computing reductions associated with incremental lowering of systolic and diastolic blood pressures. In both populations, lower levels of blood pressure predicted lower event rates, with no evidence of a plateau or a J-shaped curve. In males, both systolic and diastolic blood pressures were significantly associated with events (P<0.001), whereas in females, only systolic blood pressure (P<0.001) predicted outcome after multivariate adjustment. Correction for measurement error in blood pressure increased risk estimates by 50%. Differences in systolic blood pressure yielded greater relative risk reductions than did differences in diastolic blood pressure in a combined population of males and females. These predictive models may be useful for risk estimation associated with hypertension in similar populations and may also be used to infer the benefits of antihypertensive therapy.

Key Words: blood pressure • coronary disease • epidemiology • hypertension, essential • models, statistical • stroke

This article has been cited by other articles:

				D. Conen, P. M. Ridker, S. Mora, J. E. Buring, and R. J. Glynn Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study Eur. Heart J., December 1, 2007; 28(23): 2937 - 2943. [Abstract] [Full Text] [PDF]

				D. Conen, R. J. Glynn, J. E. Buring, P. M Ridker, and R. Y.L. Zee Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension Hypertension, December 1, 2007; 50(6): 1114 - 1119. [Abstract] [Full Text] [PDF]

				D. Conen, P. M Ridker, J. E Buring, and R. J Glynn Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study BMJ, September 1, 2007; 335(7617): 432 - 432. [Abstract] [Full Text] [PDF]

				G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, G. Corrao, F. Q. Trevano, G. Grassi, and R. Sega Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study Hypertension, June 1, 2007; 49(6): 1265 - 1270. [Abstract] [Full Text] [PDF]

				P. M Ridker, J. E. Buring, N. Rifai, and N. R. Cook Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score JAMA, February 14, 2007; 297(6): 611 - 619. [Abstract] [Full Text] [PDF]

				R. J. Glynn and B. Rosner Comparison of Risk Factors for the Competing Risks of Coronary Heart Disease, Stroke, and Venous Thromboembolism Am. J. Epidemiol., November 15, 2005; 162(10): 975 - 982. [Abstract] [Full Text] [PDF]

				P. J. Mason, J. E. Manson, H. D. Sesso, C. M. Albert, M. J. Chown, N. R. Cook, P. Greenland, P. M Ridker, and R. J. Glynn Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women's Antioxidant Cardiovascular Study (WACS) Circulation, April 6, 2004; 109(13): 1623 - 1629. [Abstract] [Full Text] [PDF]

				H. D. Sesso, R. S. Chen, G. J. L'Italien, P. Lapuerta, W. C. Lee, and R. J. Glynn Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular Events Hypertension, November 1, 2003; 42(5): 885 - 890. [Abstract] [Full Text] [PDF]